wire - news in brief

« BACK

Health



Results 151 - 200 of 2229.


Health - Pharmacology - 09.12.2020
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Moderna's vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine tri

Pharmacology - Health - 08.12.2020
Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif * in chronic myeloid leukemia trial
At 24 weeks, asciminib nearly doubled the major molecular response (MMR) rate compared to Bosulif (bosutinib)*, in patients resistant to, or intolerant of, at least two prior tyrosine kinase inhibito

Health - 08.12.2020
COVID-19: persistent symptoms in one third of cases
Physicians in Geneva have shown that some of the troublesome symptoms of COVID-19 could last more than 6 weeks, even in patients without underlying risk factors.

Pharmacology - Health - 08.12.2020
Roche presents new data from its bispecific antibody portfolio across a range of blood cancers
Latest data to be presented at ASH 2020 includes results in non-Hodgkin lymphoma and heavily pre-treated multiple myeloma Portfolio includes two CD20xCD3 bispecifics, mosunetuzumab and glofitamab, an

Pharmacology - Health - 05.12.2020
Novartis analyses confirm benefit of Kymriah with clinically meaningful rates of complete response seen in patients with certain advanced lymphomas
Interim analysis from the investigational ELARA study shows, 65% of patients with r/r follicular lymphoma evaluated for efficacy achieved a complete response and the overall response rate was 83% 1 L

Pharmacology - Health - 04.12.2020
Novartis announces first data from REACH3 trial showing Jakavi (ruxolitinib) significantly improved outcomes in patients with steroid-resistant/dependent chronic GvHD
Results of REACH3 trial also demonstrate significant improvements in failure-free survival (FFS) and patient-reported symptoms 1 Chronic graft-versus-host disease (GvHD) is a life-threatening complic

Health - Economics / Business - 04.12.2020
Swiss TPH Symposium: Reshaping Healthcare Supply Chains
Swiss TPH Symposium: Reshaping Healthcare Supply Chains
Strong and resilient supply chains ensure the provision of quality health products and vaccines to patients, making them a central component of health systems.

Innovation - Health - 03.12.2020
Technical know-how meets humanitarian aid
Technical know-how meets humanitarian aid
Engineers from the ETH Feasibility Lab are working together with the ICRC to develop a prosthetic leg that allows easy replacement of its wearing part.

Health - Pharmacology - 02.12.2020
Roche receives FDA Emergency Use Authorization for new test to measure the level of SARS-CoV-2 antibodies
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS-CoV-2 spike protein The spike protein is the target of many COVID-19 vaccines in development This test may help identif

Health - Pharmacology - 30.11.2020
Taco mattresses take the pressure off hospitals
Taco mattresses take the pressure off hospitals
During the lockdown last spring, Julian Ferchow put his doctoral project aside to help relieve the strain on hospitals.

Health - Pharmacology - 25.11.2020
Infusion more effective than tablets: Treatment of iron anaemia in rural Africa
Infusion more effective than tablets: Treatment of iron anaemia in rural Africa
Iron-deficiency anaemia is a major concern in low income countries, especially for women. A study conducted in Tanzania has now demonstrated the advantage of iron infusion therapy over the usual treatment with iron tablets.

Health - Pharmacology - 25.11.2020
Tackling pandemic threats proactively
If we are to minimize the impact of future disease outbreaks, we must recognize the importance of immunization and invest in preemptive vaccine development, writes Tim Keys.

Health - Environment - 18.11.2020
How Particulate Matter injures airways and promotes exacerbation of pulmonary diseases
How Particulate Matter injures airways and promotes exacerbation of pulmonary diseases
An international study led by the University of Bern has investigated the effects of ambient Particulate Matter (PM) from human and natural sources on human lung cells.

Health - Pharmacology - 18.11.2020
Coronavirus: simplified, faster generation of SwissCovid app codes
The process of generating covidcodes has been significantly simplified and accelerated. Persons who have tested positive can enter their code into the SwissCovid app to inform other app users of possible exposure to the virus.

Pharmacology - Health - 13.11.2020
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
  Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced low-density lipoprotein cholesterol (LDL-C) by approximately 51% in both male and female adult p

Pharmacology - Health - 13.11.2020
Results from real-world data and post-hoc analysis of Novartis Beovu pivotal trials presented at AAO 2020
Initial findings on patient characteristics and event likelihood provide insights related to Beovu use in wet AMD 1,2   Follows establishment of multi-disciplinary expert coalition and Novartis commi

Health - 11.11.2020
Survey on the psychological effects of the second Covid-19 wave
Survey on the psychological effects of the second Covid-19 wave
The results of a survey conducted by the University of Basel showed that the pandemic's first wave put a great deal of psychological strain on many people in Switzerland.

Health - Innovation - 10.11.2020
GHF 2020: putting humans at the forefront of global health
GHF 2020: putting humans at the forefront of global health
The coronavirus crisis is a powerful indicator of the global challenges facing the health sector. The eighth Geneva Health Forum will pull together key players in the quest for concrete solutions.

Microtechnics - Health - 09.11.2020

Health - Pharmacology - 06.11.2020
Novartis provides update on CAN-COVID trial in hospitalized patients
The Phase III trial investigating canakinumab plus standard of care (SoC) did not meet its primary endpoint of a greater chance of patient survival without the need for invasive mechanical ventilatio

Health - Life Sciences - 05.11.2020

Life Sciences - Health - 05.11.2020
A new generation of optogenetic tools for research and medicine
A new generation of optogenetic tools for research and medicine
The European Research Council (ERC) is providing 10 million euros in funding for an interdisciplinary, collaborative project in the structural and biophysical analysis of selected photoreceptors and t

Pharmacology - Health - 05.11.2020
Novartis Cosentyx shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
Significant reduction of synovitis (joint lining inflammation) was demonstrated with Cosentyx   at Week 12  vs.

Health - Life Sciences - 04.11.2020

Environment - Health - 03.11.2020
Successful network research is extended
Successful network research is extended
Sleep, religious conflicts and the health of the environment, plants, humans and animals: these are the topics of the three Interfaculty Research Cooperations at the University of Bern.

Health - Environment - 03.11.2020
Mapping to predict the distribution of ticks in Switzerland
Mapping to predict the distribution of ticks in Switzerland
A comprehensive study by EPFL and Lausanne University Hospital (CHUV) has enabled researchers to map the geographical distribution of ticks in Switzerland for the first time, as well as to determine whether they are carriers of chlamydia. Little is known about these bacteria, but ticks can potentially pass them to humans.

Health - Life Sciences - 03.11.2020
Significant vulnerability in prostate cancer detected
Significant vulnerability in prostate cancer detected
Researchers at the University of Bern led an international team that has identified a novel vulnerability in advanced prostate cancer that is no longer responding to hormonal therapy. These findings could lead to the development of new treatment approaches for men suffering from the most aggressive form of prostate cancer.

Health - Pharmacology - 30.10.2020
Contact tracing with prophylactic treatment could near-eliminate leprosy
Contact tracing with prophylactic treatment could near-eliminate leprosy
Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programmes, and is generally well accepted by patients, their contacts, and healthcare workers.

Pharmacology - Health - 29.10.2020
Novartis presents latest Phase III data reinforcing Cosentyx as a first-line systemic treatment in pediatric psoriasis
Latest data show Cosentyx provides fast and strong skin clearance, significant improvement in quality of life and a favorable safety profile 1,2   Moderate-to-severe psoriasis affects more than 350,0

Health - Pharmacology - 29.10.2020
Novartis acquires Vedere Bio, adding novel optogenetic gene therapy technology for treating blindness
Acquisition expands the Novartis footprint in ophthalmology and enhances the company's position as an AAV-based gene therapy powerhouse.

Health - Computer Science - 27.10.2020
New system uses floor vibrations to detect building occupants
New system uses floor vibrations to detect building occupants
Thanks to a new system developed at EPFL, building owners can detect the number of occupants and track their movement using sensors installed on floor slabs.